top of page

Proven Regenerative Medicine Leader

Sam-DSC00344-Edit_Web.jpg

Samuel Lynch, DMSc, DMD

Founder / Chairman / CEO

LRM-Mark-FINAL_PrimaryMark.png
LRM-Mark-FINAL_PrimaryMark.png
LRM-Mark-FINAL_PrimaryMark.png
LRM-Mark-FINAL_PrimaryMark.png
LRM-Mark-FINAL_PrimaryMark.png

Double doctorates:

  • Harvard medical sciences and periodontal medicine.

 

Vanderbilt University Medical Center (VUMC) & Nashville Biosciences (NB):

  • Founding member Board of Directors of independent VUMC & NB

  • Chair of Audit and Compliance Committee - VUMC (5 years)

  • Chair of Compensation and Leadership Committee - VUMC (3 years)

​

Internationally recognized expert in regenerative medicine:

  • >200 patents and publications

  • Hundreds of invited lectures in 25+ countries

​

3-time Founder & CEO (all highly successful exists):

  1. Osteohealth Co. 

    • Now a division of Geistlich Pharma

  2. BioMimetic Therapeutics [Nasdaq: BMTI]

    • IPO then trade sale, Now a division of Stryker, Inc.​

  3. Lynch Biologics, LLC.​

    • Private sale to Geistlich Pharma NA for undisclosed amount​​​

​​

Southeast Medical Device Association Entrepreneur of the Year

three blocks.png
LRM-Logo-FINAL-_Primary.png

Executive Leadership

Finance

Manufacturing

Regulatory

Quality systems

Facial

Skin Rejuvenation / Facial Aesthetics

  • Sales to Aesthetic Providers

  • Marketing

  • Direct Pay

Wound application.jpg

Skin Regeneration / Wound Care

  • Sales to wound care clinics, hospitals, podiatrists

  • Marketing

  • Reimbursement

Our Medical Advisors & Investigators

three blocks.png

Technology has been Developed in Collaboration with Scientists from Around the World…

Below are the Clinical Investigators Committed to Performing the Next Clinical Trials

bottom of page